Roberto Lúcio Muniz Júnior1, Isabella Piassi Godói2,3,4, Edna Afonso Reis5, Marina Morgado Garcia6,7, Augusto Afonso Guerra-Júnior2,3, Brian Godman6,7,8,9, Cristina Mariano Ruas2. 1. a College of Pharmacy - Universidade Federal de Minas Gerais, Av. Presidente Antônio Carlos, 6627 , Campus Pampulha, Belo Horizonte, Minas Gerais, CEP 31270-901 , Brazil. 2. b Programa de Pós-graduação em Medicamentos e Assistência Farmacêutica, sala 1023, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Av. Presidente Antônio Carlos, 6627 , Campus Pampulha, Belo Horizonte, Minas Gerais, CEP 31270-901 , Minas Gerais , Brazil. 3. c SUS Collaborating Centre for Technology Assessment and Excellence in Health, sala 1042, Faculdade de Farmácia , Universidade Federal de Minas Gerais, Av. Presidente Antônio Carlos, 6627, Campus Pampulha, Belo Horizonte, Minas Gerais, CEP 31270-901 , Brazil. 4. d Institute of Health and Biological Studies - Universidade Federal do Sul e Sudeste do Pará, Avenida dos Ipês , s/n, Cidade Universitária, Cidade Jardim, Marabá , Pará , Brazil. 5. e Department of Statistics - Exact Sciences Institute - Universidade Federal de Minas Gerais (UFMG) - Av. Presidente Antônio Carlos 6627 - Pampulha - CEP 31.270-901 - Belo Horizonte , Brazil. 6. f Strathclyde Institute of Pharmacy and Biomedical Sciences , Strathclyde University , Glasgow , United Kington. 7. g Division of Clinical Pharmacology , Karolinska Institutet, Karolinska University Hospital , Stockholm , Sweden. 8. h Health Economics Centre , Liverpool University Management School , Liverpool , UK. 9. i Department of Public Health Pharmacy and Management, School of Pharmacy , Sefako Makgatho Health Sciences University , Garankuwa , South Africa.
Abstract
ABSTRACT Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. METHODS: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. RESULTS: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). CONCLUSION: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.
ABSTRACT Background: Zika virus is a newly emerging infection, associated with increasingly large outbreaks especially in tropical countries such as Brazil. A future Zika vaccine can contribute to decreasing the number of cases and associated complications. Information about consumers' willingness to pay (WTP) for a hypothetical Zika vaccine can help price setting discussions in the future in Brazil, starting with the private market. METHODS: A cross-sectional study conducted among residents of Minas Gerais, Brazil, regarding their WTP for a hypothetical Zika Vaccine. The mean effective protection was 80%, with the possibility of some local and systemic side- effects. RESULTS: 517 people were interviewed. However, 28 would not be vaccinated even if the vaccine was free. Most of the resultant interviewees (489) were female (58.2%), had completed high school (49.7%), were employed (71.2%), had private health insurance (52.7%), and did not have Zika (96.9%). The median individual maximum WTP for this hypothetical Zika vaccine (one dose) was US$31.34 (BRL100.00). CONCLUSION: Such discussions regarding WTP can contribute to decision-making about prices once a Zika vaccine becomes available in Brazil alongside other ongoing programs to control the virus.